The Misleading QRS Morphology of Scar-Related Ventricular Tachycardia
- PMID: 40874895
- DOI: 10.1016/j.jacep.2025.07.004
The Misleading QRS Morphology of Scar-Related Ventricular Tachycardia
Abstract
Background: The QRS morphology of ventricular tachycardia (VT) reflects the re-entry circuit exit location and helps guide mapping for radiofrequency ablation (RFA). It can be misleading, however, particularly in structural heart disease.
Objective: The aim of this study was to assess the relation of the site where RFA terminated VT to the location of the exit predicted by the VT QRS morphology.
Methods: This study included 64 scar-related re-entrant left ventricular VTs (57.9% ischemic cardiomyopathy) with an identified region where RFA terminated the VT; a previously reported electrocardiogram algorithm that uses the QRS vector to predict the VT exit region on the American Heart Association 17-segment left ventricular model was applied. QRS discordant VTs were defined as having the RFA termination site outside of the predicted exit region. Entrainment and pace mapping (PM) data were also analyzed to assess possible reasons for discrepancies.
Results: The QRS morphology was discordant with the termination region in 57 (89%) VTs. Two types of discordance were seen. In 22 (34.4%), the termination region was remote from the circuit exit. In 32 (50%), the termination site was in the VT re-entry circuit exit, but the QRS suggested a different exit region. Analysis of voltage maps and PM suggested that the QRS vector was often altered by scar.
Conclusions: For scar-related VTs, the exit predicted from a vector-based QRS algorithm often differs from the location where ablation terminates the VT. This is an important consideration for use of the QRS to guide VT ablation strategies. PM can potentially assist in recognizing this discrepancy and warrants study.
Keywords: catheter ablation; electroanatomical mapping; electrocardiogram; pace mapping; ventricular tachycardia.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author disclosures Dr Katsume and Dr Togashi have each received a scholarship from the Japanese Heart Rhythm Society. Dr Uetake has received support from Mitsukoshi Health and Welfare Foundation and Fukuda Foundation for medical technology. Dr Richardson has received speaking honoraria from Medtronic and research funding from Medtronic and Abbott; and has served as a consultant for Philips and Johnson & Johnson. Dr Kanagasundram has received speaking honoraria from Abbott and Johnson & Johnson. Dr Tandri has received research support from Abbott. Dr Stevenson has received speaking honoraria from Abbott, Boston Scientific, Johnson & Johnson, MediaSphere, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
LinkOut - more resources
Full Text Sources